# Catalogue global des sources potentielles pour Vectora Inbox.
# Ce fichier est partagé par toutes les verticales (LAI, gene therapy, cell therapy, etc.)
# et par tous les clients. Il répond à la question :
# "Quelles sources (RSS, APIs, etc.) Vectora Inbox sait lire ?"

sources:
  # ========================================================================
  # SOURCES CORPORATE LAI
  # ========================================================================
  # Sources de type "press_corporate" associées à la verticale LAI.
  # Ces sources correspondent aux sites institutionnels des principaux
  # acteurs pharmaceutiques et biotechs travaillant sur les LAI.
  - source_key: "press_corporate__89bio"
    source_type: "press_corporate"
    url: "https://89bio.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de 89bio. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__abbvie"
    source_type: "press_corporate"
    url: "https://www.abbvie.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de AbbVie. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__activate_therapeutics"
    source_type: "press_corporate"
    url: "https://www.activatetherapeutics.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Activate Therapeutics. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__adare_pharmaceuticals"
    source_type: "press_corporate"
    url: "https://adarepharmasolutions.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Adare Pharmaceuticals. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__adocia"
    source_type: "press_corporate"
    url: "https://www.adocia.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Adocia. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__akari_therapeutics"
    source_type: "press_corporate"
    url: "https://akaritx.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Akari Therapeutics. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__akero_therapeutics"
    source_type: "press_corporate"
    url: "https://akerotx.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Akero Therapeutics. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__alar_pharmaceuticals"
    source_type: "press_corporate"
    url: "https://alarpharm.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Alar Pharmaceuticals. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__alcon"
    source_type: "press_corporate"
    url: "https://www.alcon.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Alcon. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__alexion_pharmaceuticals"
    source_type: "press_corporate"
    url: "https://alexion.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Alexion Pharmaceuticals. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__alk_abello"
    source_type: "press_corporate"
    url: "https://www.alk.com"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de ALK-Abello. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__alkermes"
    source_type: "press_corporate"
    url: "https://www.alkermes.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Alkermes. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__allay_therapeutics"
    source_type: "press_corporate"
    url: "https://www.allaytx.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Allay Therapeutics. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__allysta_pharmaceuticals"
    source_type: "press_corporate"
    url: "https://www.allysta.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Allysta Pharmaceuticals. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__alma_therapeutics"
    source_type: "press_corporate"
    url: "https://www.almatherapeutics.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Alma Therapeutics. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__alteogen"
    source_type: "press_corporate"
    url: "https://alteogen.com"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Alteogen. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__amgen"
    source_type: "press_corporate"
    url: "https://www.amgen.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Amgen. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__amplicore"
    source_type: "press_corporate"
    url: "https://www.amplicorepharma.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Amplicore. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__anhui_anke_biotechnology"
    source_type: "press_corporate"
    url: "https://www.ankebio.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Anhui Anke Biotechnology. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__ankyra_therapeutics"
    source_type: "press_corporate"
    url: "https://ankyratx.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Ankyra Therapeutics. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__anthos_therapeutics"
    source_type: "press_corporate"
    url: "https://anthostherapeutics.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Anthos Therapeutics. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__antlia_bioscience"
    source_type: "press_corporate"
    url: "https://antliabio.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Antlia Bioscience. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__aprilbio"
    source_type: "press_corporate"
    url: "http://www.aprilbio.com/en"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de AprilBio. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__asahi_kasei_pharma"
    source_type: "press_corporate"
    url: "https://www.asahi-kasei.co.jp/pharma/en/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Asahi Kasei Pharma. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__ascendis_pharma"
    source_type: "press_corporate"
    url: "https://ascendispharma.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Ascendis Pharma. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__ascletis_biopharmaceutical"
    source_type: "press_corporate"
    url: "https://www.ascletis.com/Index/index/index/l/en-us.html"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Ascletis Biopharmaceutical. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__asta_medica_baxter"
    source_type: "press_corporate"
    url: "https://www.baxter.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de ASTA Medica (Baxter). Point d'entrée pour les news LAI."
  - source_key: "press_corporate__astellas_pharma"
    source_type: "press_corporate"
    url: "https://www.astellas.com/en/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Astellas Pharma. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__astrazeneca"
    source_type: "press_corporate"
    url: "https://www.astrazeneca.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de AstraZeneca. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__astria_therapeutics"
    source_type: "press_corporate"
    url: "https://astriatx.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Astria Therapeutics. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__bayer"
    source_type: "press_corporate"
    url: "https://www.bayer.com/en/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Bayer. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__beone"
    source_type: "press_corporate"
    url: "https://beonemedicines.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de BeOne. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__betta_pharmaceuticals"
    source_type: "press_corporate"
    url: "https://www.bettapharma.com/en.php"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Betta Pharmaceuticals. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__biocon"
    source_type: "press_corporate"
    url: "https://www.biocon.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Biocon. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__bioverativ"
    source_type: "press_corporate"
    url: "https://www.sanofi.com/en"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Bioverativ. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__bolder_biotechnology"
    source_type: "press_corporate"
    url: "https://www.bolderbio.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Bolder BioTechnology. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__boston_pharmaceuticals"
    source_type: "press_corporate"
    url: "https://www.bostonpharmaceuticals.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Boston Pharmaceuticals. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__braeburn"
    source_type: "press_corporate"
    url: "https://braeburnrx.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Braeburn. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__brii_biosciences"
    source_type: "press_corporate"
    url: "https://www.briibio.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Brii Biosciences. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__cali_pharmaceuticals"
    source_type: "press_corporate"
    url: "https://www.calibiosciences.com/EN"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Cali Pharmaceuticals. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__camurus"
    source_type: "press_corporate"
    url: "https://www.camurus.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Camurus. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__canwell_pharma"
    source_type: "press_corporate"
    url: "https://canwellpharma.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Canwell Pharma. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__carmot_therapeutics"
    source_type: "press_corporate"
    url: "https://www.gene.com/carmot"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Carmot Therapeutics. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__cheplapharm"
    source_type: "press_corporate"
    url: "https://www.cheplapharm.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de CHEPLAPHARM. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__chong_kun_dang_holdings"
    source_type: "press_corporate"
    url: "https://www.ckd-holdings.com/en/home"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Chong Kun Dang Holdings. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__chongqing_chen_an_biopharmaceutical_co_ltdco_ltd"
    source_type: "press_corporate"
    url: ""
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Chongqing Chen'an Biopharmaceutical Co LtdCo Ltd. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__chugai_pharmaceutical"
    source_type: "press_corporate"
    url: "https://www.chugai.com"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Chugai Pharmaceutical. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__cidara_therapeutics"
    source_type: "press_corporate"
    url: "https://www.cidara.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Cidara Therapeutics. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__cipla_usa"
    source_type: "press_corporate"
    url: "https://usa.cipla.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Cipla USA. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__consegna_pharma"
    source_type: "press_corporate"
    url: "https://www.consegnapharma.com/pipeline"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Consegna Pharma. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__contura"
    source_type: "press_corporate"
    url: "https://contura.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Contura. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__covis_pharma"
    source_type: "press_corporate"
    url: "https://covispharma.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Covis Pharma. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__cristal_therapeutics"
    source_type: "press_corporate"
    url: "https://cristaltherapeutics.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Cristal Therapeutics. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__csl_behring"
    source_type: "press_corporate"
    url: "https://www.csl.com/we-are-csl/our-businesses-and-products/csl-behring"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de CSL Behring. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__daewon_pharm"
    source_type: "press_corporate"
    url: "https://www.daewonpharm.com/eng/main/index.jsp"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Daewon Pharm. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__daewoong_pharmaceutical"
    source_type: "press_corporate"
    url: "https://crm.daewoong.co.kr/eng/main"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Daewoong Pharmaceutical. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__dare_bioscience"
    source_type: "press_corporate"
    url: "https://darebioscience.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Dare Bioscience. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__debiopharm"
    source_type: "press_corporate"
    url: "https://www.debiopharm.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Debiopharm. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__debiopharm_international"
    source_type: "press_corporate"
    url: "https://www.debiopharm.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Debiopharm International. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__delsitech"
    source_type: "press_corporate"
    url: "https://www.delsitech.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de DelSiTech. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__durect"
    source_type: "press_corporate"
    url: "https://www.bauschhealth.com/durect/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Durect. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__eagle_pharmaceuticals"
    source_type: "press_corporate"
    url: "https://www.eagleus.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Eagle Pharmaceuticals. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__eisai"
    source_type: "press_corporate"
    url: "https://www.eisai.com/index.html"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Eisai. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__eli_lilly"
    source_type: "press_corporate"
    url: "https://www.lilly.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Eli Lilly. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__endo_international"
    source_type: "press_corporate"
    url: "https://www.endo.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Endo International. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__enhanx_biopharm"
    source_type: "press_corporate"
    url: "https://www.enhanxbiopharm.eu/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de EnhanX Biopharm. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__eupraxia_pharmaceuticals"
    source_type: "press_corporate"
    url: "https://eupraxiapharma.gcs-web.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Eupraxia Pharmaceuticals. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__exavir_therapeutics"
    source_type: "press_corporate"
    url: "https://www.exavirtherapeutics.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Exavir Therapeutics. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__ferring"
    source_type: "press_corporate"
    url: "https://www.ferring.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Ferring. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__foresee_pharmaceuticals"
    source_type: "press_corporate"
    url: "https://www.foreseepharma.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Foresee Pharmaceuticals. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__frontier_biotechnologies"
    source_type: "press_corporate"
    url: "https://en.frontierbiotech.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Frontier Biotechnologies. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__g2gbio"
    source_type: "press_corporate"
    url: "https://www.g2gbio.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de G2GBio. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__genexine"
    source_type: "press_corporate"
    url: "http://www.genexine.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Genexine. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__gilead_sciences"
    source_type: "press_corporate"
    url: "https://www.gilead.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Gilead Sciences. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__glaxosmithkline"
    source_type: "press_corporate"
    url: "https://www.gsk.com/en-gb/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de GlaxoSmithKline. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__hanmi_pharmaceutical"
    source_type: "press_corporate"
    url: "https://www.hanmipharm.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Hanmi Pharmaceutical. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__hansoh_pharmaceutical"
    source_type: "press_corporate"
    url: "https://www.hspharm.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Hansoh Pharmaceutical. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__harrow"
    source_type: "press_corporate"
    url: "https://www.harrow.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Harrow. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__heron_therapeutics"
    source_type: "press_corporate"
    url: "https://www.herontx.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Heron Therapeutics. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__immunoforge_co"
    source_type: "press_corporate"
    url: "https://www.immunoforge.com/en/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Immunoforge Co. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__immunwork"
    source_type: "press_corporate"
    url: "https://www.immunwork.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Immunwork. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__imv"
    source_type: "press_corporate"
    url: "https://www.imv-technologies.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de IMV. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__indivior"
    source_type: "press_corporate"
    url: "https://www.indivior.com/en"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Indivior. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__insitu_biologics"
    source_type: "press_corporate"
    url: "https://insitubiologics.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de InSitu Biologics. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__intra_cellular_therapies"
    source_type: "press_corporate"
    url: "https://www.intracellulartherapies.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Intra-Cellular Therapies. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__ipsen"
    source_type: "press_corporate"
    url: "https://www.ipsen.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Ipsen. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__janssen"
    source_type: "press_corporate"
    url: "https://www.jnj.com/innovativemedicine/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Janssen. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__janssen_pharmaceuticals"
    source_type: "press_corporate"
    url: "https://google.com/search?q=Janssen+Pharmaceuticals.com&sca_esv=1a46a2fefbdb7a46&rlz=1C1VDKB_frFR1089FR1089&sxsrf=AE3TifOreNmLNJadnYFm7PdDKHeCPi5ieA%3A1762640101644&ei=5cAPaemNJ-aikdUPx6WP6QQ&ved=0ahUKEwiplICJyuOQAxVmUaQEHcfSI00Q4dUDCBE&uact=5&oq=Janssen+Pharmaceuticals.com&gs_lp=Egxnd3Mtd2l6LXNlcnAiG0phbnNzZW4gUGhhcm1hY2V1dGljYWxzLmNvbTIGEAAYFhgeMgYQABgWGB4yBhAAGBYYHjIGEAAYFhgeMgYQABgWGB4yBhAAGBYYHjIGEAAYFhgeSMUNUL8FWL4IcAF4AZABAJgBVaABvAKqAQE0uAEDyAEA-AEBmAIFoALoAsICChAAGEcY1gQYsAPCAg0QABiABBiKBRhDGLADwgIOEAAY5AIY1gQYsAPYAQHCAhkQLhiABBiKBRhDGMcBGNEDGMgDGLAD2AEBwgITEC4YgAQYigUYQxjIAxiwA9gBAcICCBAAGBYYHhgKmAMAiAYBkAYRugYGCAEQARgJkgcBNaAHhBqyBwE0uAfYAsIHBTItNC4xyAcl&sclient=gws-wiz-serp"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Janssen Pharmaceuticals. Point d'entrée pour les news LAI. (URL de recherche générique à nettoyer manuellement)"
  - source_key: "press_corporate__jazz_pharmaceuticals"
    source_type: "press_corporate"
    url: "https://www.jazzpharma.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Jazz Pharmaceuticals. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__jcr_pharmaceuticals"
    source_type: "press_corporate"
    url: "https://jcrpharm.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de JCR Pharmaceuticals. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__jiangsu_hengrui_medicine"
    source_type: "press_corporate"
    url: "https://www.hengrui.com/en/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Jiangsu Hengrui Medicine. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__jiangxi_puheng_pharmaceuticals_ltd_lidds_ab"
    source_type: "press_corporate"
    url: ""
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Jiangxi Puheng Pharmaceuticals Ltd; LIDDS AB. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__laboratorios_farmaceuticos_rovi"
    source_type: "press_corporate"
    url: "https://www.rovi.es/en/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Laboratorios Farmaceuticos Rovi. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__leadermed_health_group_ltd"
    source_type: "press_corporate"
    url: ""
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de LeaderMed Health Group Ltd;. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__lee_s_pharmaceutical_holdings"
    source_type: "press_corporate"
    url: "https://www.leespharm.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Lee's Pharmaceutical Holdings. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__lepu_medical_technology_beijing_co_ltd"
    source_type: "press_corporate"
    url: "https://fr.lepumedical.com/explore-lepu-products-in-your-language.html"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Lepu Medical Technology (Beijing) Co Ltd. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__lidds"
    source_type: "press_corporate"
    url: "https://liddspharma.com/en/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de LIDDS. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__lipocure"
    source_type: "press_corporate"
    url: "https://lipocurerx.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de LipoCure. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__lisata_therapeutics_inc_qilu_pharmaceutical_co_ltd"
    source_type: "press_corporate"
    url: "https://www.lisata.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Lisata Therapeutics Inc; Qilu Pharmaceutical Co Ltd. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__ltt_bio_pharma_co"
    source_type: "press_corporate"
    url: "https://www.ltt.co.jp/en/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de LTT Bio-Pharma Co. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__lundbeck"
    source_type: "press_corporate"
    url: "https://www.lundbeck.com/global"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Lundbeck. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__luye_pharma"
    source_type: "press_corporate"
    url: "https://www.luye.cn/lvye_en/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Luye Pharma. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__mallinckrodt"
    source_type: "press_corporate"
    url: "https://www.mallinckrodt.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Mallinckrodt. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__mapi_pharma"
    source_type: "press_corporate"
    url: "https://mapi-pharma.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Mapi Pharma. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__medincell"
    source_type: "press_corporate"
    url: "https://www.medincell.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de MedinCell. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__merck_co"
    source_type: "press_corporate"
    url: "https://www.merck.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Merck & Co. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__metsera"
    source_type: "press_corporate"
    url: "https://metsera.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Metsera. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__molecular_partners"
    source_type: "press_corporate"
    url: "https://www.molecularpartners.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Molecular Partners. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__mundipharma"
    source_type: "press_corporate"
    url: "https://fr.mundipharma.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Mundipharma. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__nanology"
    source_type: "press_corporate"
    url: "https://nanology.us/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de NanOlogy. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__neuraly"
    source_type: "press_corporate"
    url: "https://www.neuralymed.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Neuraly. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__nkd_pharm"
    source_type: "press_corporate"
    url: "https://www.nkdpharm.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de NKD Pharm. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__novartis"
    source_type: "press_corporate"
    url: ""
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Novartis. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__novo_nordisk"
    source_type: "press_corporate"
    url: "https://www.novonordisk.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Novo Nordisk. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__omeros"
    source_type: "press_corporate"
    url: "https://www.omeros.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Omeros. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__opko_health"
    source_type: "press_corporate"
    url: "https://www.opko.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de OPKO Health. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__original_biomedicals_implants"
    source_type: "press_corporate"
    url: "https://originalbiomedicalimplants.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Original BioMedicals Implants. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__pacira_biosciences"
    source_type: "press_corporate"
    url: "https://www.pacira.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Pacira BioSciences. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__painreform"
    source_type: "press_corporate"
    url: "https://painreform.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de PainReform. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__pdx_pharmaceuticals"
    source_type: "press_corporate"
    url: "https://www.pdxpharm.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de PDX Pharmaceuticals. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__peptron"
    source_type: "press_corporate"
    url: "https://www.google.com/search?q=Peptron&rlz=1C1VDKB_frFR1089FR1089&oq=Peptron&gs_lcrp=EgZjaHJvbWUyBggAEEUYOdIBBzE3OWowajeoAgCwAgA&sourceid=chrome&ie=UTF-8"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Peptron. Point d'entrée pour les news LAI. (URL de recherche générique à nettoyer manuellement)"
  - source_key: "press_corporate__peregrine_ophthalmic"
    source_type: "press_corporate"
    url: "https://peregrineophthalmic.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Peregrine Ophthalmic. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__persica_pharmaceuticals"
    source_type: "press_corporate"
    url: "https://persicapharmaceuticals.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Persica Pharmaceuticals. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__pfizer"
    source_type: "press_corporate"
    url: "https://www.pfizer.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Pfizer. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__pharmaessentia"
    source_type: "press_corporate"
    url: "https://pharmaessentiamedical.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de PharmaEssentia. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__phasebio_pharmaceuticals"
    source_type: "press_corporate"
    url: "https://phasebio.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de PhaseBio Pharmaceuticals. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__polypid"
    source_type: "press_corporate"
    url: "https://www.polypid.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de PolyPid. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__prolynx"
    source_type: "press_corporate"
    url: "https://prolynxinc.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Prolynx. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__protheragen"
    source_type: "press_corporate"
    url: "https://www.protheragen.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Protheragen. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__quiapeg_pharmaceuticals"
    source_type: "press_corporate"
    url: "https://www.quiapeg.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de QuiaPEG Pharmaceuticals. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__rebelmedicine"
    source_type: "press_corporate"
    url: "https://www.rebelmedicine.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de RebelMedicine. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__recordati"
    source_type: "press_corporate"
    url: "https://recordati.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Recordati. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__regeneron_pharmaceuticals"
    source_type: "press_corporate"
    url: "https://www.regeneron.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Regeneron Pharmaceuticals. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__reliance_life_sciences"
    source_type: "press_corporate"
    url: "https://www.rellife.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Reliance Life Sciences. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__revance_therapeutics"
    source_type: "press_corporate"
    url: "https://www.revance.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Revance Therapeutics. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__rhythm_pharmaceuticals"
    source_type: "press_corporate"
    url: "https://rhythmtx.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Rhythm Pharmaceuticals. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__roxall_medizin"
    source_type: "press_corporate"
    url: "https://www.roxall.com"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Roxall Medizin. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__samyang_corp"
    source_type: "press_corporate"
    url: "https://www.samyangcorp.com/en/index"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Samyang Corp. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__sanofi"
    source_type: "press_corporate"
    url: "https://www.sanofi.com/en"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Sanofi. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__scilex_holding"
    source_type: "press_corporate"
    url: "https://www.scilexholding.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Scilex Holding. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__serina_therapeutics"
    source_type: "press_corporate"
    url: "https://www.serinatx.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Serina Therapeutics. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__shionogi_co"
    source_type: "press_corporate"
    url: "https://www.shionogi.com/global/en/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Shionogi & Co. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__silexion_therapeutics"
    source_type: "press_corporate"
    url: "https://silexion.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Silexion Therapeutics. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__sonoran_biosciences"
    source_type: "press_corporate"
    url: "https://www.sonoranbiosciences.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Sonoran Biosciences. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__spectrum_pharmaceuticals"
    source_type: "press_corporate"
    url: "https://www.spectrumtherapeutics.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Spectrum Pharmaceuticals. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__spinethera"
    source_type: "press_corporate"
    url: "https://www.frenellepharma.com/spinethera"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de SpineThera. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__spinnaker_biosciences"
    source_type: "press_corporate"
    url: "https://www.spinnakerbiosciences.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Spinnaker Biosciences. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__spiral_therapeutics"
    source_type: "press_corporate"
    url: "https://www.spiraltx.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Spiral Therapeutics. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__sun_pharmaceutical"
    source_type: "press_corporate"
    url: "https://sunpharma.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Sun Pharmaceutical. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__synartro"
    source_type: "press_corporate"
    url: "https://synartro.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Synartro. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__taiwan_liposome"
    source_type: "press_corporate"
    url: "https://www.tlcbio.com/en"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Taiwan Liposome. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__takeda_pharmaceutical"
    source_type: "press_corporate"
    url: "https://www.takeda.com"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Takeda Pharmaceutical. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__targtex"
    source_type: "press_corporate"
    url: "https://targtex.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de TargTex. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__teva_pharmaceutical"
    source_type: "press_corporate"
    url: "https://www.tevapharm.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Teva Pharmaceutical. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__theraly_fibrosis"
    source_type: "press_corporate"
    url: "https://www.tedcomd.com/portfolio/theraly-fibrosis"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Theraly Fibrosis. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__urogen_pharma"
    source_type: "press_corporate"
    url: "https://www.urogen.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de UroGen Pharma. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__vanda_pharmaceuticals"
    source_type: "press_corporate"
    url: "https://www.vandapharma.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Vanda Pharmaceuticals. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__vasa_therapeutics"
    source_type: "press_corporate"
    url: "https://vasatherapeutics.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Vasa Therapeutics. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__vifor_pharma"
    source_type: "press_corporate"
    url: "https://www.csl.com/we-are-csl/our-businesses-and-products/csl-vifor"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Vifor Pharma. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__viiv_healthcare"
    source_type: "press_corporate"
    url: "https://viivhealthcare.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de ViiV Healthcare. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__viriom"
    source_type: "press_corporate"
    url: "https://www.viriom.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Viriom. Point d'entrée pour les news LAI."
  - source_key: "press_corporate__zealand_pharma"
    source_type: "press_corporate"
    url: "https://www.zealandpharma.com/"
    default_language: "en"
    vertical_tags: ["lai"]
    notes: "Site institutionnel / corporate de Zealand Pharma. Point d'entrée pour les news LAI."

  # ========================================================================
  # SOURCES D'API SCIENTIFIQUES & RÉGLEMENTAIRES
  # ========================================================================
  # Sources d'API globales (PubMed, ClinicalTrials.gov, FDA labels).
  # Ces sources permettent d'interroger des bases de données publiques pour
  # récupérer des publications scientifiques, des essais cliniques et des
  # informations réglementaires. Le filtrage (ex: LAI) se fait via des requêtes
  # construites par la Lambda.

  - source_key: "science_pubmed_api"
    source_type: "api_pubmed"
    url: "https://eutils.ncbi.nlm.nih.gov/entrez/eutils/"
    default_language: "en"
    vertical_tags: ["science", "pharma-biotech"]
    notes: >
      API NCBI E-utilities pour interroger PubMed. Le filtrage (ex: LAI)
      se fait via des requêtes construites par la Lambda. L'authentification
      peut utiliser une clé stockée dans AWS Systems Manager Parameter Store,
      accessible via une variable d'environnement (ex: PUBMED_API_KEY_PARAM).

  - source_key: "trials_ctgov_api"
    source_type: "api_clinicaltrials"
    url: "https://clinicaltrials.gov/api/v2/"
    default_language: "en"
    vertical_tags: ["trials", "pharma-biotech"]
    notes: >
      API ClinicalTrials.gov pour interroger les essais cliniques. Le filtrage
      (ex: LAI) se fait via des paramètres de requête construits par la Lambda.
      Aucun secret n'est requis pour un MVP (API publique).

  - source_key: "reg_fda_labels_api"
    source_type: "api_fda_labels"
    url: "https://api.fda.gov/drug/label.json"
    default_language: "en"
    vertical_tags: ["regulatory", "pharma-biotech"]
    notes: >
      API openFDA pour récupérer les drug labels. Peut être utilisée pour des
      produits LAI (ou d'autres verticales). L'accès de base est public, mais
      l'utilisation d'une clé API reste possible pour augmenter les limites
      de requêtes si nécessaire.

  # ========================================================================
  # PRESSE PHARMA / BIOTECH PREMIUM
  # ========================================================================
  # Presse sectorielle pharmaceutique / biotech (ex: FiercePharma, Endpoints, etc.).
  # Ces sources sont de type "press_sector" avec le tag "pharma-biotech".

  - source_key: "press_sector__applied_clinical_trials"
    source_type: "press_sector"
    url: "https://placeholder/applied-clinical-trials.rss"
    default_language: "en"
    vertical_tags: ["pharma-biotech"]
    notes: "Presse essais cliniques / CRO (Applied Clinical Trials)."
  - source_key: "press_sector__biocentury"
    source_type: "press_sector"
    url: "https://placeholder/biocentury.rss"
    default_language: "en"
    vertical_tags: ["pharma-biotech"]
    notes: "Presse biotech / venture / IPO (BioCentury)."
  - source_key: "press_sector__biospace"
    source_type: "press_sector"
    url: "https://placeholder/biospace.rss"
    default_language: "en"
    vertical_tags: ["pharma-biotech"]
    notes: "Presse emploi / actu biotech (BioSpace)."
  - source_key: "press_sector__bioworld"
    source_type: "press_sector"
    url: "https://placeholder/bioworld.rss"
    default_language: "en"
    vertical_tags: ["pharma-biotech"]
    notes: "Presse biotech/pharma avec focus deals et régulation (BioWorld)."
  - source_key: "press_sector__drug_discovery_today"
    source_type: "press_sector"
    url: "https://placeholder/drug-discovery-today.rss"
    default_language: "en"
    vertical_tags: ["pharma-biotech"]
    notes: "Presse R&D / drug discovery (Drug Discovery Today)."
  - source_key: "press_sector__firstword_pharma"
    source_type: "press_sector"
    url: "https://placeholder/firstword-pharma.rss"
    default_language: "en"
    vertical_tags: ["pharma-biotech"]
    notes: "Presse pharma orientée deals / réglementation (FirstWord Pharma)."
  - source_key: "press_sector__genetic_engineering_news"
    source_type: "press_sector"
    url: "https://placeholder/genetic-engineering-news.rss"
    default_language: "en"
    vertical_tags: ["pharma-biotech"]
    notes: "Presse biotech / gene therapy / génomique (GEN)."
  - source_key: "press_sector__labiotech"
    source_type: "press_sector"
    url: "https://placeholder/labiotech.rss"
    default_language: "en"
    vertical_tags: ["pharma-biotech"]
    notes: "Presse biotech européenne (Labiotech)."
  - source_key: "press_sector__nature_biotechnology"
    source_type: "press_sector"
    url: "https://placeholder/nature-biotechnology.rss"
    default_language: "en"
    vertical_tags: ["pharma-biotech"]
    notes: "Presse scientifique / biotech (Nature Biotechnology)."
  - source_key: "press_sector__pharmaceutical_commerce"
    source_type: "press_sector"
    url: "https://placeholder/pharmaceutical-commerce.rss"
    default_language: "en"
    vertical_tags: ["pharma-biotech"]
    notes: "Presse supply chain / distribution pharma (Pharmaceutical Commerce)."
  - source_key: "press_sector__pharmaceutical_technology"
    source_type: "press_sector"
    url: "https://placeholder/pharmaceutical-technology.rss"
    default_language: "en"
    vertical_tags: ["pharma-biotech"]
    notes: "Presse pharma / manufacturing / innovation (Pharmaceutical Technology)."
  - source_key: "press_sector__pharmaphorum"
    source_type: "press_sector"
    url: "https://placeholder/pharmaphorum.rss"
    default_language: "en"
    vertical_tags: ["pharma-biotech"]
    notes: "Presse sectorielle pharma / digital health (pharmaphorum)."
  - source_key: "press_sector__pharmatimes"
    source_type: "press_sector"
    url: "https://placeholder/pharmatimes.rss"
    default_language: "en"
    vertical_tags: ["pharma-biotech"]
    notes: "Presse sectorielle pharma (PharmaTimes, UK/EU)."
  - source_key: "press_sector__pink_sheet"
    source_type: "press_sector"
    url: "https://placeholder/pink-sheet.rss"
    default_language: "en"
    vertical_tags: ["pharma-biotech"]
    notes: "Presse premium centrée réglementation / FDA (Pink Sheet)."
  - source_key: "press_sector__scrip_intelligence"
    source_type: "press_sector"
    url: "https://placeholder/scrip-intelligence.rss"
    default_language: "en"
    vertical_tags: ["pharma-biotech"]
    notes: "Presse pharma, accès au marché et pricing (Scrip Intelligence)."
  - source_key: "press_sector__fiercepharma"
    source_type: "press_sector"
    url: "https://www.fiercepharma.com/"
    default_language: "en"
    vertical_tags: ["pharma-biotech"]
    notes: "Presse sectorielle orientée industrie pharmaceutique (FiercePharma)."
  - source_key: "press_sector__fiercebiotech"
    source_type: "press_sector"
    url: "https://www.fiercebiotech.com/"
    default_language: "en"
    vertical_tags: ["pharma-biotech"]
    notes: "Presse sectorielle orientée biotech (FierceBiotech)."
  - source_key: "press_sector__fiercehealthcare"
    source_type: "press_sector"
    url: "https://www.fiercehealthcare.com/"
    default_language: "en"
    vertical_tags: ["pharma-biotech"]
    notes: "Presse sectorielle orientée systèmes de santé / payers (FierceHealthcare)."
  - source_key: "press_sector__endpoints_news"
    source_type: "press_sector"
    url: "https://endpoints.news/"
    default_language: "en"
    vertical_tags: ["pharma-biotech"]
    notes: "Presse sectorielle biotech/pharma (Endpoints News)."

bouquets:
  # ========================================================================
  # BOUQUETS LAI
  # ========================================================================
  # Bouquets liés à la verticale LAI (ex: sources corporate LAI).
  # Ces bouquets regroupent les sources pertinentes pour la veille LAI.

  - bouquet_id: "lai_corporate_mvp"
    description: "Sous-bouquet MVP : quelques sites corporate LAI avec URLs valides pour tester l'ingestion."
    source_keys:
      - "press_corporate__medincell"
      - "press_corporate__camurus"
      - "press_corporate__g2gbio"
      - "press_corporate__alkermes"
      - "press_corporate__indivior"
      - "press_corporate__ascendis_pharma"
      - "press_corporate__novo_nordisk"
      - "press_corporate__ipsen"

  - bouquet_id: "lai_corporate_all"
    description: "Bouquet pour les flux corporate des principaux acteurs LAI."
    source_keys:
      - "press_corporate__89bio"
      - "press_corporate__abbvie"
      - "press_corporate__activate_therapeutics"
      - "press_corporate__adare_pharmaceuticals"
      - "press_corporate__adocia"
      - "press_corporate__akari_therapeutics"
      - "press_corporate__akero_therapeutics"
      - "press_corporate__alar_pharmaceuticals"
      - "press_corporate__alcon"
      - "press_corporate__alexion_pharmaceuticals"
      - "press_corporate__alk_abello"
      - "press_corporate__alkermes"
      - "press_corporate__allay_therapeutics"
      - "press_corporate__allysta_pharmaceuticals"
      - "press_corporate__alma_therapeutics"
      - "press_corporate__alteogen"
      - "press_corporate__amgen"
      - "press_corporate__amplicore"
      - "press_corporate__anhui_anke_biotechnology"
      - "press_corporate__ankyra_therapeutics"
      - "press_corporate__anthos_therapeutics"
      - "press_corporate__antlia_bioscience"
      - "press_corporate__aprilbio"
      - "press_corporate__asahi_kasei_pharma"
      - "press_corporate__ascendis_pharma"
      - "press_corporate__ascletis_biopharmaceutical"
      - "press_corporate__asta_medica_baxter"
      - "press_corporate__astellas_pharma"
      - "press_corporate__astrazeneca"
      - "press_corporate__astria_therapeutics"
      - "press_corporate__bayer"
      - "press_corporate__beone"
      - "press_corporate__betta_pharmaceuticals"
      - "press_corporate__biocon"
      - "press_corporate__bioverativ"
      - "press_corporate__bolder_biotechnology"
      - "press_corporate__boston_pharmaceuticals"
      - "press_corporate__braeburn"
      - "press_corporate__brii_biosciences"
      - "press_corporate__cali_pharmaceuticals"
      - "press_corporate__camurus"
      - "press_corporate__canwell_pharma"
      - "press_corporate__carmot_therapeutics"
      - "press_corporate__cheplapharm"
      - "press_corporate__chong_kun_dang_holdings"
      - "press_corporate__chongqing_chen_an_biopharmaceutical_co_ltdco_ltd"
      - "press_corporate__chugai_pharmaceutical"
      - "press_corporate__cidara_therapeutics"
      - "press_corporate__cipla_usa"
      - "press_corporate__consegna_pharma"
      - "press_corporate__contura"
      - "press_corporate__covis_pharma"
      - "press_corporate__cristal_therapeutics"
      - "press_corporate__csl_behring"
      - "press_corporate__daewon_pharm"
      - "press_corporate__daewoong_pharmaceutical"
      - "press_corporate__dare_bioscience"
      - "press_corporate__debiopharm"
      - "press_corporate__debiopharm_international"
      - "press_corporate__delsitech"
      - "press_corporate__durect"
      - "press_corporate__eagle_pharmaceuticals"
      - "press_corporate__eisai"
      - "press_corporate__eli_lilly"
      - "press_corporate__endo_international"
      - "press_corporate__enhanx_biopharm"
      - "press_corporate__eupraxia_pharmaceuticals"
      - "press_corporate__exavir_therapeutics"
      - "press_corporate__ferring"
      - "press_corporate__foresee_pharmaceuticals"
      - "press_corporate__frontier_biotechnologies"
      - "press_corporate__g2gbio"
      - "press_corporate__genexine"
      - "press_corporate__gilead_sciences"
      - "press_corporate__glaxosmithkline"
      - "press_corporate__hanmi_pharmaceutical"
      - "press_corporate__hansoh_pharmaceutical"
      - "press_corporate__harrow"
      - "press_corporate__heron_therapeutics"
      - "press_corporate__immunoforge_co"
      - "press_corporate__immunwork"
      - "press_corporate__imv"
      - "press_corporate__indivior"
      - "press_corporate__insitu_biologics"
      - "press_corporate__intra_cellular_therapies"
      - "press_corporate__ipsen"
      - "press_corporate__janssen"
      - "press_corporate__janssen_pharmaceuticals"
      - "press_corporate__jazz_pharmaceuticals"
      - "press_corporate__jcr_pharmaceuticals"
      - "press_corporate__jiangsu_hengrui_medicine"
      - "press_corporate__jiangxi_puheng_pharmaceuticals_ltd_lidds_ab"
      - "press_corporate__laboratorios_farmaceuticos_rovi"
      - "press_corporate__leadermed_health_group_ltd"
      - "press_corporate__lee_s_pharmaceutical_holdings"
      - "press_corporate__lepu_medical_technology_beijing_co_ltd"
      - "press_corporate__lidds"
      - "press_corporate__lipocure"
      - "press_corporate__lisata_therapeutics_inc_qilu_pharmaceutical_co_ltd"
      - "press_corporate__ltt_bio_pharma_co"
      - "press_corporate__lundbeck"
      - "press_corporate__luye_pharma"
      - "press_corporate__mallinckrodt"
      - "press_corporate__mapi_pharma"
      - "press_corporate__medincell"
      - "press_corporate__merck_co"
      - "press_corporate__metsera"
      - "press_corporate__molecular_partners"
      - "press_corporate__mundipharma"
      - "press_corporate__nanology"
      - "press_corporate__neuraly"
      - "press_corporate__nkd_pharm"
      - "press_corporate__novartis"
      - "press_corporate__novo_nordisk"
      - "press_corporate__omeros"
      - "press_corporate__opko_health"
      - "press_corporate__original_biomedicals_implants"
      - "press_corporate__pacira_biosciences"
      - "press_corporate__painreform"
      - "press_corporate__pdx_pharmaceuticals"
      - "press_corporate__peptron"
      - "press_corporate__peregrine_ophthalmic"
      - "press_corporate__persica_pharmaceuticals"
      - "press_corporate__pfizer"
      - "press_corporate__pharmaessentia"
      - "press_corporate__phasebio_pharmaceuticals"
      - "press_corporate__polypid"
      - "press_corporate__prolynx"
      - "press_corporate__protheragen"
      - "press_corporate__quiapeg_pharmaceuticals"
      - "press_corporate__rebelmedicine"
      - "press_corporate__recordati"
      - "press_corporate__regeneron_pharmaceuticals"
      - "press_corporate__reliance_life_sciences"
      - "press_corporate__revance_therapeutics"
      - "press_corporate__rhythm_pharmaceuticals"
      - "press_corporate__roxall_medizin"
      - "press_corporate__samyang_corp"
      - "press_corporate__sanofi"
      - "press_corporate__scilex_holding"
      - "press_corporate__serina_therapeutics"
      - "press_corporate__shionogi_co"
      - "press_corporate__silexion_therapeutics"
      - "press_corporate__sonoran_biosciences"
      - "press_corporate__spectrum_pharmaceuticals"
      - "press_corporate__spinethera"
      - "press_corporate__spinnaker_biosciences"
      - "press_corporate__spiral_therapeutics"
      - "press_corporate__sun_pharmaceutical"
      - "press_corporate__synartro"
      - "press_corporate__taiwan_liposome"
      - "press_corporate__takeda_pharmaceutical"
      - "press_corporate__targtex"
      - "press_corporate__teva_pharmaceutical"
      - "press_corporate__theraly_fibrosis"
      - "press_corporate__urogen_pharma"
      - "press_corporate__vanda_pharmaceuticals"
      - "press_corporate__vasa_therapeutics"
      - "press_corporate__vifor_pharma"
      - "press_corporate__viiv_healthcare"
      - "press_corporate__viriom"
      - "press_corporate__zealand_pharma"

  # ========================================================================
  # BOUQUETS SCIENTIFIQUES & RÉGLEMENTAIRES (APIs)
  # ========================================================================
  # Bouquets liés aux APIs globales (PubMed, ClinicalTrials.gov, FDA labels).
  # Ces bouquets permettent d'interroger des bases de données publiques pour
  # récupérer des publications scientifiques, des essais cliniques et des
  # informations réglementaires sur des thèmes spécifiques (ex: LAI).

  - bouquet_id: "science_pubmed_lai"
    description: >
      Bouquet pour interroger PubMed sur des requêtes LAI (requêtes construites
      côté Lambda ou config).
    source_keys:
      - "science_pubmed_api"

  - bouquet_id: "trials_ctgov_lai"
    description: >
      Bouquet pour interroger ClinicalTrials.gov sur les études cliniques LAI
      (filtres construits côté Lambda ou config).
    source_keys:
      - "trials_ctgov_api"

  - bouquet_id: "reg_fda_labels_lai"
    description: >
      Bouquet pour interroger l'API openFDA sur des labels de produits LAI.
      La sélection des produits/termes LAI est gérée côté Lambda ou config.
    source_keys:
      - "reg_fda_labels_api"

  # ========================================================================
  # BOUQUETS PRESSE / BIOTECH
  # ========================================================================
  # Bouquets de presse sectorielle pharma / biotech.
  # Ces bouquets regroupent les sources de presse spécialisée pour la veille
  # sectorielle (actualités, deals, réglementation, essais cliniques, etc.).

  - bouquet_id: "press_biotech_premium"
    description: "Bouquet pour une sélection de sites de presse biotech/pharma."
    source_keys:
      - "press_sector__applied_clinical_trials"
      - "press_sector__biocentury"
      - "press_sector__biospace"
      - "press_sector__bioworld"
      - "press_sector__drug_discovery_today"
      - "press_sector__endpoints_news"
      - "press_sector__fiercebiotech"
      - "press_sector__fiercehealthcare"
      - "press_sector__fiercepharma"
      - "press_sector__firstword_pharma"
      - "press_sector__genetic_engineering_news"
      - "press_sector__labiotech"
      - "press_sector__nature_biotechnology"
      - "press_sector__pharmaceutical_commerce"
      - "press_sector__pharmaceutical_technology"
      - "press_sector__pharmaphorum"
      - "press_sector__pharmatimes"
      - "press_sector__pink_sheet"
      - "press_sector__scrip_intelligence"
